Pharming Group Nv (PHAR) has released an update.
Pharming Group N.V. has announced the launch of a new €100 million convertible bond offering due 2029, with an invitation to repurchase existing €125 million bonds due 2025. The new bonds will carry a 4.50% annual coupon and are set to be issued at a significant premium over the current share price. The company plans to use the proceeds to strengthen its financial position and support its business strategy in the coming years.
For further insights into PHAR stock, check out TipRanks’ Stock Analysis page.
